Tactile Systems Technology (TCMD)
(Delayed Data from NSDQ)
$14.18 USD
+0.06 (0.42%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $14.17 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$14.18 USD
+0.06 (0.42%)
Updated Oct 9, 2024 04:00 PM ET
After-Market: $14.17 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Zacks News
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Tactile Medical Stock Rises After Positive Flexitouch Trial Results
by Zacks Equity Research
TCMD announces a new study evaluating Flexitouch. The study reveals significant improvements in health-related quality of life and clinical outcomes.
Implied Volatility Surging for Tactile Systems (TCMD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tactile Systems (TCMD) stock based on the movements in the options market lately.
Tactile Medical's Shares Rise After PDAC Approval for Nimbl
by Zacks Equity Research
TCMD's Nimbl pneumatic compression system gets CMS PDAC approval and is set to be launched in the United States soon, following FDA clearance for treating lymphedema.
Does Tactile Systems Technology (TCMD) Have the Potential to Rally 57.31% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 57.3% in Tactile Systems Technology (TCMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tactile Systems Technology (TCMD) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Tactile Systems Technology (TCMD) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 100% and 0.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 54.55% and 3.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Tactile Systems Technology (TCMD) concluded the recent trading session at $14.44, signifying a +0.7% move from its prior day's close.
Investors Heavily Search Tactile Systems Technology, Inc. (TCMD): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Tactile Systems Technology (TCMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of 7.27% and 6.88%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
Tactile Systems Technology (TCMD) concluded the recent trading session at $14.30, signifying a +0.21% move from its prior day's close.
Tactile Systems Technology and ESCO Technologies have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Tactile Systems Technology and ESCO Technologies are part of the Zacks Bull and Bear of the Day article.
Bull Of The Day: Tactile Systems Technology (TCMD)
by Brian Bolan
This company has a history of crushing the number which always helps send earnings estimates higher.
Wall Street Analysts See Tactile Systems Technology (TCMD) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Tactile Systems Technology (TCMD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Tactile Systems Technology (TCMD) Stock Moves -0.14%: What You Should Know
by Zacks Equity Research
Tactile Systems Technology (TCMD) closed the most recent trading day at $14.14, moving -0.14% from the previous trading session.
Is Tactile Systems Technology (TCMD) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here is What to Know Beyond Why Tactile Systems Technology, Inc. (TCMD) is a Trending Stock
by Zacks Equity Research
Tactile Systems Technology (TCMD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
New Strong Buy Stocks for April 16th
by Zacks Equity Research
TCMD, QUAD, YPF, AMAT and PTLO have been added to the Zacks Rank #1 (Strong Buy) List on April 16, 2024.
Tactile Systems Technology (TCMD) Declines More Than Market: Some Information for Investors
by Zacks Equity Research
In the closing of the recent trading day, Tactile Systems Technology (TCMD) stood at $14.78, denoting a -1.79% change from the preceding trading day.
New Strong Buy Stocks for April 5th
by Zacks Equity Research
CSTM, TCMD, GEF, OWL and TPL have been added to the Zacks Rank #1 (Strong Buy) List on April 5, 2023.
Tactile Systems Technology (TCMD) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Tactile Systems Technology (TCMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).